Phase I clinical trials In early phase development, time really is money. The sooner you can make a go/no-go decision, the sooner you can allocate resources to optimize the development of your portfolio. Parexel has a well-earned reputation for helping clients move quickly in early development...
Kip Cosmo GB•1 review 5 days ago Don't do a clinical trial with this… Don't do a clinical trial with this company. One of the worst experiences of my life. The nurses were often exhausted from being up all night. And worse, some were simply crude and incompetent, uncompromising an...
Clinical Trials (78) Consulting (19) CRA (33) Data Management (11) Finance (11) Functional Service Provider (71) Human Resources (3) IT (17) Medical Sciences (20) Medical Writing (5) Procurement (2) Project Leadership (6) Quality Management (2) Re-excel (2) Regul...
Clinical trials fail for various reasons, including inadequate basic science, flawed study design, suboptimal dosing, poor study operations, slow enrollment, high dropout rates, and unproven clinical or commercial value.1 However, assessing the feasibilit...
Leveraging the breadth of our clinical, regulatory, and therapeutic expertise, our team of more than 24,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators, and sites to design and deliver clinical trials with patients in mind, increasing access and pa......
Review Clinical Trials Specialist (离职员工) - Durham, NC - 2012年8月10日 Parexel is a great company to work for. One's experience is contingent upon personality, and overall professional skill set. Co-worker are extremely friendly. 优点 friendly environment 缺点 disorganized 这篇点评对您有用吗...
Parexel supports the development of innovative new medicines to improve the health of patients. We provide services to help life sciences and biopharmaceutical customers everywhere transform scientific discoveries into new treatments. From decentralized clinical trials to regulatory consulting services...
Smith made significant contributions to increase the number of lymphoma clinical trials – helping to bring a new drug to market to treat relapsed Hodgkin’s lymphoma while working to change the standard of care for patients. Dr. Smith’s experience also includes serving as Execu...
11、s.All those factors are important for understanding the right patient profile for clinical trials,the primary and secondary endpoints,and where a treatment is most likely to demonstrate improvement.There are several ways to collect information about the patient journey during asset planning:Intervie...